About the Authors

Kevin P. Weinfurt

kevin.weinfurt@duke.edu

Affiliations Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America

Damon M. Seils

Affiliation Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

Janice P. Tzeng

Current address: University of North Carolina School of Public Health, Chapel Hill, North Carolina, United States of America

Affiliation Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

Li Lin

Affiliation Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

Kevin A. Schulman

Affiliations Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America

Robert M. Califf

Affiliations Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America

Competing Interests

Dr. Weinfurt reports receiving research and/or salary support from Bristol-Myers Squibb, Inspire Pharmaceuticals, Johnson & Johnson, and Novartis; and receiving personal income for consulting from Inspire Pharmaceuticals. Dr. Schulman reports receiving research and/or salary support from Actelion, Allergan, Amgen, Arthritis Foundation, Astellas Pharma, Bristol-Myers Squibb, The Duke Endowment, Genentech, Inspire Pharmaceuticals, Johnson & Johnson, Kureha Corporation, LifeMasters Supported SelfCare, Medtronic, Merck, Nabi Biopharmaceuticals, National Patient Advocate Foundation, North Carolina Biotechnology Center, Novartis, OSI Eyetech, Pfizer, Roche, Sanofi-Aventis, Schering-Plough, Scios, Tengion, Theravance, Thomson Healthcare, Vertex Pharmaceuticals, Wyeth, and Yamanouchi USA Foundation; receiving personal income for consulting from Avalere Health, LifeMasters Supported SelfCare, McKinsey & Company, and the National Pharmaceutical Council; having equity in Alnylam Pharmaceuticals; having equity in and serving on the board of directors of Cancer Consultants, Inc; and having equity in and serving on the executive board of Faculty Connection, LLC. Dr. Califf reports receiving personal income for consulting from Bayer, Conceptis, and Kowa Research Institute. Dr. Califf also reports that all personal income for consulting is donated to nonprofit organizations, with the majority going to the research fellowship fund of the Duke Clinical Research Institute. Educational activities by Dr. Califf generate revenue for Duke University from Conceptis and Kowa Research Institute. Drs. Weinfurt, Schulman, and Califf have made available online detailed listings of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Mr. Seils, Ms. Tzeng, and Ms. Lin did not report any financial disclosures. Dr. Schulman serves on the editorial boards of the American Heart Journal, The American Journal of Medicine, Cost Effectiveness and Resource Allocation, Health Services Research, and Value in Health. Dr. Califf is the editor in chief of the American Heart Journal and serves on the editorial boards of Cardiosource Clinical Trials; Circulation; Clinical Trials; European Heart Journal; Heart, Lung and Circulation; Journal of Cardiovascular Risk; The Journal of Invasive Cardiology; Journal of the American College of Cardiology; and MedWorks Media.

Author Contributions

Conceived and designed the experiments: DS KW JT KS RC. Performed the experiments: KW LL. Analyzed the data: DS KW JT KS RC LL. Wrote the paper: DS KW. Other: Acquired the data: DS JT. Revised the paper for important intellectual content: DS LL JT RC KW KS. Obtained funding: KS RC KW. Provided administrative support: RC. Supervised the study: KW.